Read more

Cardiolyse Cardiac Analytics solution in COVID-19 Disruptive circumstances

Cardiolyse aims to support the high-risk groups’ cardiac health monitoring and management in Coronavirus pandemic circumstances At the disruptive times with the COVID-19 outbreak growing Cardiolyse is all-hands ready to expand the availability of our platform and deliver the solution to those of high cardiac risk and elderly people currently isolated at home or restricted from safe & easy medical […]

Cardiolyse presenting its solution at Arab Health 2020

Moving on with our global partners’ outreach Good news this time comes from Dubai, where Arab Health, the leading healthcare business event in the Middle East has taken place. Cardiolyse was represented by our business development advisor, Normunds Daudiss. We were selected to deliver a pitch at Innov8 talks and Normunds has won the first day of competition, presenting Cardiolyse […]

Cardiolyse pitched at corporate challenges at HTH Styria Pitch & Partner event

Greetings from Graz, Austria! The part of our team is these days participating in HTH Styria Pitch & Partner event #HTHStyria. Cardiolyse has been selected out of 70+ companies to present our solution on 2 corporate challenges out of 4 organized by the event hosts. It’s been two insightful days of great inspiration, deep and productive networking, as well as […]

CE certificate for class IIa software medical device issued

A year of new achievements and new happiness started just perfectly with Cardiolyse finally receiving its CE and ISO certification papers! We’re certified as a standalone software medical device for automatic ECG interpretation, which now fully opens all the doors for sustainable commercial partnerships with hospitals, pharmacies, GP networks, and other digital health market disruptive players. Within the certification process, […]

Cardiolyse was issued with a US patent for its proprietary Method of ECG evaluation

One of Cardiolyse product core technologies for the unique Method of ECG Evaluation to deliver personalized cardiac risk assessment has been issued with the US patent! The patent covers the invention of the Universal ECG Score, which is designed to diagnose the cardiovascular system based on at least 148 quantitative ECG parameters rating and aggregation. The score calculated provides the […]